Kiniksa Pharmaceuticals International (KNSA) Cash from Financing Activities (2018 - 2026)
Kiniksa Pharmaceuticals International's Cash from Financing Activities came in at $12.11 million for Q2 2026, up 13.2% from $10.7 million a year earlier and up 99.4% from the prior quarter.
Kiniksa Pharmaceuticals International (KNSA) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Kiniksa Pharmaceuticals International reported Cash from Financing Activities of $37.74 million, up 69.3% year-over-year; for FY2025, it came in at $33.02 million, up 169.2% from FY2024.
- Cash from Financing Activities carries a five-year compound annual growth rate of -32.0% (FY2020 to FY2025).
- Going back by year, Cash from Financing Activities was $12.27 million in FY2024 (+720.5%), $1.5 million in FY2023 (-40.6%), $2.52 million in FY2022 (-57.2%) and $5.89 million in FY2021 (-97.4%).
- The Q2 2026 figure represents the highest quarterly Cash from Financing Activities since Q3 2020.
- Year-over-year, Cash from Financing Activities has increased for four consecutive quarters, with growth averaging 108.8% over the last six quarters.
- The fastest year-over-year change in Cash from Financing Activities over five years came in Q4 2025 (growth of 257.5%), and the weakest in Q3 2021 (a decline of 98.2%).
- Business Quant data shows KNSA's Cash from Financing Activities at $6.07 million (Q1 2026), $7.66 million (Q4 2025) and $11.9 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Kiniksa Pharmaceuticals International | 11.64 Bn | 10.38 Bn | 220.03 Mn | 12.11 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.11 Mn |
| Mar 31, 2026 | 6.07 Mn |
| Dec 31, 2025 | 7.66 Mn |
| Sep 30, 2025 | 11.90 Mn |
| Jun 30, 2025 | 10.70 Mn |
| Mar 31, 2025 | 2.77 Mn |
| Dec 31, 2024 | 2.14 Mn |
| Sep 30, 2024 | 6.69 Mn |
| Jun 30, 2024 | -178,000.00 |
| Mar 31, 2024 | 3.61 Mn |
| Dec 31, 2023 | 695,000.00 |
| Sep 30, 2023 | 552,000.00 |
| Jun 30, 2023 | 158,000.00 |
| Mar 31, 2023 | 90,000.00 |
| Dec 31, 2022 | 1.19 Mn |
| Sep 30, 2022 | 361,000.00 |
| Jun 30, 2022 | 542,000.00 |
| Mar 31, 2022 | 423,000.00 |
| Dec 31, 2021 | 1.21 Mn |
| Sep 30, 2021 | 2.68 Mn |
Kiniksa Pharmaceuticals International Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();